ITEM 9 LABS (INLB) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 104 247 sessions, September 1, 2023 to September 4, 2024
- Largest daily move
- +100% close of March 20, 2024
- 1-year change
- -99.3% closing prices, September 1, 2023 to September 4, 2024
- 1-month change
- +0% closing prices, August 2, 2024 to September 4, 2024
Company Description
ITEM 9 LABS (OTC: INLB) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $10.2K.
INLB has declined 99.3% over the past year. The last closing price was $0.0001.
For FY2022, ITEM 9 LABS reported revenue of $21.8M with net income of -$31.2M and diluted earnings per share of -$0.33. The company operates at a net profit margin of -143.3%.
This page collects what Stock Titan holds for INLB, including price data, latest news, and financial highlights.
Stock Performance
ITEM 9 LABS (INLB) closed at $0.0001 on September 4, 2024. Over the past 12 months, the price has lost 99.3%.
INLB Metrics & Rankings
Price returns through September 4, 2024. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
ITEM 9 LABS has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 7 with negative movement. Key topics include conferences. View all INLB news →
SEC Filings
Financial Highlights
ITEM 9 LABS generated $21.8M in revenue in FY2022, retaining a 33.6% gross margin, operating income reached -$23.1M (-106.0% operating margin), and net income was -$31.2M, reflecting a -143.3% net profit margin. Diluted earnings per share stood at -$0.33. The company generated -$2.3M in operating cash flow. The current ratio was 0.09, measuring current assets divided by current liabilities.
Upcoming Events
INLB Company Profile & Sector Positioning
ITEM 9 LABS (INLB) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing INLB often look at related companies in the same sector, including HALO COLLECTIVE INC (HCANF), AVIVAGEN INC (VIVXF), BLOOMIOS INC (BLMS), VERITAS FARMS INC (VFRM), and ONASSIS HOLDINGS CORP (ONSS). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate INLB's relative position within its industry.